Aaron Cowen Suvretta Capital Management
Aaron Cowen is the founder of Suvretta Capital Management, a long/short equity firm with a fundamental research process. The firm invests across sectors with an emphasis on differentiated fundamental views. Cowen’s disclosures are tracked by investors who follow mid-to-large fundamental hedge funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$60.1M |
| 2 |
Amazon
AMZN
|
+$54.1M |
| 3 |
Yum! Brands
YUM
|
+$51M |
| 4 |
Royalty Pharma
RPRX
|
+$39.8M |
| 5 |
ETNB
89bio
ETNB
|
+$28.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$102M |
| 2 |
Tapestry
TPR
|
+$83M |
| 3 |
Las Vegas Sands
LVS
|
+$78.1M |
| 4 |
Union Pacific
UNP
|
+$56.7M |
| 5 |
AT&T
T
|
+$54.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 48.7% |
| 2 | Consumer Discretionary | 12.85% |
| 3 | Technology | 6.69% |
| 4 | Communication Services | 5.61% |
| 5 | Consumer Staples | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Dollar General
DG
$27.2B
| – | – |
-173,850
| Closed | -$42.8M |
|
102
GFL Environmental
GFL
$14.8B
| – | – |
-753,818
| Closed | -$22M |
|
103
Genmab
GMAB
$20.6B
| – | – |
-5,210
| Closed | -$221K |
|
|
104
Las Vegas Sands
LVS
$30.5B
| – | – |
-1,625,685
| Closed | -$78.1M |
|
105
NVIDIA
NVDA
$5.2T
| – | – |
-873,580
| Closed | -$12.8M |
|
|
106
Otis Worldwide
OTIS
$27.2B
| – | – |
-1,297,480
| Closed | -$102M |
|
107
Prothena Corp
PRTA
$485M
| – | – |
-206,448
| Closed | -$12.4M |
|
108
Ross Stores
ROST
$76.7B
| – | – |
-105,040
| Closed | -$12.2M |
|
|
SCHW
109
Charles Schwab
SCHW
$194B
| – | – |
-604,204
| Closed | -$50.3M |
|
|
110
AT&T
T
$173B
| – | – |
-2,951,900
| Closed | -$54.3M |
|
111
Bio-Techne
TECH
$11.3B
| – | – |
-2,600
| Closed | -$215K |
|
|
112
Tapestry
TPR
$26B
| – | – |
-2,180,922
| Closed | -$83M |
|
|
VTYX
113
DELISTED
Ventyx Biosciences
VTYX
| – | – |
-186,400
| Closed | -$6.11M |
|
114
State Street Energy Select Sector SPDR ETF
XLE
$41.7B
| – | – |
-685,140
| Closed | -$30M |
|
|
PNT
115
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| – | – |
-2,627,000
| Closed | -$19.2M |
|
Similar funds
Aaron Cowen's Q1 2023 Portfolio in Review
As of Q1 2023, Aaron Cowen held 115 positions worth $2.37B, down 0.57% from $2.38B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Aaron Cowen's Q1 2023 filing shows 26 new, 36 increased, 14 reduced and 20 closed positions. Its largest new stake was Amazon: 559,490 shares worth $57.8M. The largest sale was Otis Worldwide, an estimated $102M.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, up from 47% a quarter earlier, followed by Consumer Discretionary and Technology.
- Aaron Cowen's largest Q1 2023 buy was Amazon: 559,490 shares worth $57.8M.
- Aaron Cowen added most to Elevance Health in Q1 2023, an estimated $60.1M increase.
- Aaron Cowen's biggest Q1 2023 reduction was Union Pacific, cutting an estimated $56.7M.
- Aaron Cowen fully exited Otis Worldwide in Q1 2023, selling an estimated $102M.
- Aaron Cowen's ten largest holdings make up 39% of its $2.37B portfolio in Q1 2023.
- Aaron Cowen opened 26 new positions and closed 20 in Q1 2023.
- Aaron Cowen's portfolio value fell 0.57% quarter-over-quarter to $2.37B.
Based on Suvretta Capital Management's 13F filing for Q1 2023, filed 15 May 2023.